Published in
Elsevier, Annals of Oncology, (31), p. S1156, 2020
DOI: 10.1016/j.annonc.2020.08.2253
Links
Tools
LBA24 TROPHY-U-01 cohort 1 final results: A phase II study of sacituzumab govitecan (SG) in metastatic urothelial cancer (mUC) that has progressed after platinum (PLT) and checkpoint inhibitors (CPI)
Journal article published in 2020 by
Y. Loriot,
A. V. Balar 
,
D. P. Petrylak,
S. T. Tagawa,
A. Rezazadeh,
A. Fléchon,
R. Jain,
N. Agarwal,
M. Bupathi,
P. Barthélémy,
P. Beuzeboc,
P. L. Palmbos,
C. E. Kyriakopoulos,
D. Pouessel,
C. N. Sternberg
and other authors.
,
D. P. Petrylak,
S. T. Tagawa,
A. Rezazadeh,
A. Fléchon,
R. Jain,
N. Agarwal,
M. Bupathi,
P. Barthélémy,
P. Beuzeboc,
P. L. Palmbos,
C. E. Kyriakopoulos,
D. Pouessel,
C. N. Sternberg
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 